Company Filing History:
Years Active: 2008
Title: The Innovations of Russ Tsao
Introduction
Russ Tsao is an accomplished inventor based in Tenafly, NJ (US). He has made significant contributions to the field of synthetic metabolites, particularly through his innovative work on CCI-779 derivatives. His expertise and dedication to research have led to advancements that may impact various applications in medicine and pharmacology.
Latest Patents
Russ Tsao holds a patent for "CCI-779 derivatives and methods of making same." This patent describes a method of generating synthetic metabolites of CCI-779. It details five novel CCI-779 derivatives and outlines methods for using these derivatives to detect CCI-779 metabolites in samples. This work represents a significant step forward in the understanding and application of CCI-779 in scientific research.
Career Highlights
Tsao is currently employed at Wyeth, a company known for its commitment to innovation in the pharmaceutical industry. His role at Wyeth has allowed him to collaborate with other talented professionals and contribute to groundbreaking research. His work has not only advanced his career but has also contributed to the broader scientific community.
Collaborations
Throughout his career, Russ Tsao has worked alongside notable colleagues such as Ping Cai and Mark Edward Ruppen. These collaborations have fostered an environment of innovation and creativity, leading to the development of new ideas and solutions in their field.
Conclusion
Russ Tsao's contributions to the field of synthetic metabolites through his patent on CCI-779 derivatives exemplify the impact of dedicated research and collaboration. His work at Wyeth and partnerships with other professionals highlight the importance of innovation in advancing scientific knowledge.